Beta Glucan 500 and Biological Age and Immune Age
Completed · Phase 2
Conditions studied: Aging
In brief
The primary purpose of this study is to evaluate the effects of BWH Labs - Beta Glucan 500 on biomarkers of biological and immune age among healthy adults. A single-arm, open-label prospective study will be conducted evaluating the impact of 12 weeks of supplementation with two capsules daily of Beta Glucan 500 on a variety of validated markers of biological and immune age on the comprehensive TruAge panel (TruDiagnostics, Lexington, KY).
Key facts
- Study ID
- NCT07104929
- Run by
- OvationLab
- People needed
- 60
- Starts
- 2025-05-14
- Expected to finish
- 2025-10-09
- Last updated by the study team
- 2026-02-19
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adult females or males age ≥ 40 years
- Ability to read and speak English
- Previous completion of a TruDiagnostic TruAge test within the past three months to enable comparison of previous biomarkers to the same biomarkers after intervention
- DunedinPACE estimate of aging >0.9
You may not qualify if…
- Current diagnosis and treatment for an autoimmune condition
- Current use of beta-glucan or mushroom dietary supplement
- Known allergies to beta glucan, yeast, or mushrooms
- Currently pregnant or lactating women or women planning to become pregnant in the next 12 weeks
- Current diagnosis of a chronic health condition (e.g., cancer, heart failure, history of pancreatitis, type I or II diabetics on insulin) deemed clinically contraindicated for the study protocol
- Participants unable to provide consent
Where it is running
- OvationLab — Richmond, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.